Filing metadata

Accession number
0001104659-24-063516
Form type
Form 3
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
May 20, 2024
Reporting period
May 16, 2024
Description
Initial ownership

Explore SEC Filings Hub